|
⚲
|
| Keyboard |
| LB Pharmaceuticals Inc
✚
|
|
|---|---|
| CIK # | 0001691082 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001691082] | |
| 10-Q | [0001691082] | |
| 3 | [0001691082] | |
| 4 | [0001691082] | |
| 8-K | [0001691082] | |
| D | [0001691082] | |
| SC 13G | [0001691082] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
LB Pharmaceuticals Inc LBRX
Stock Option (Right to Buy) · derivative
|
2026-03-06 | Grant | 20,000 | $0.00 | |
|
LB Pharmaceuticals Inc LBRX
Pre-Funded Warrants (Right to Buy) · derivative
|
2026-02-06 | Buy | 93,925 | $21.17 | 1,988,392 |
|
LB Pharmaceuticals Inc LBRX
Pre-Funded Warrants (Right to Buy) · derivative
|
2026-02-06 | Buy | 378,444 | $21.17 | 8,011,659 |
|
LB Pharmaceuticals Inc LBRX
Employee Stock Option (Right to Buy) · derivative
|
2025-12-10 | Grant | 195,000 | $0.00 |